Adverse Event

Views Updated: Dec 15, 2025

Abbreviation

Pronunciation

/ˌædˈvərs ɪˈvɛnt/

The FDA has conducted a new analysis of the available literature and post-marketing adverse event reports.
Patient survival and severe adverse event rates were similar in both groups.
The FDA is continuing to review adverse event reports and evaluate ways to reduce unintended exposures to these products.
No patient had a drug-related serious adverse event or discontinued because of toxicity.
No data are available to support a correlation between RGV and adverse event rates.

United Arab Emirates Regional

American English Academic

American Embassy Gov

American Edition Academic

Account Executive Business

Association Executive Community

Associate Editor Misc

Alter Ego Community

Artisan Edition Misc

and AE Misc